News >

Searching for Novel Agents to Augment Atezolizumab Approval in Small Cell Lung Cancer

Caroline Seymour
Published: Monday, Jul 22, 2019

Stephen V. Liu, MD

Stephen Liu, MD

Despite the integration of frontline immunotherapy into routine practice for patients with extensive-stage small cell lung cancer (SCLC), researchers are still searching for agents with a high clinical impact that do more than fill a space of unmet need, explained Stephen V. Liu, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication